Evidence map›Paper›PMID 29439963›Full record

ArticleAntimicrobial agents and chemotherapy2018

Arindam P Ghosh, Cheri Aycock, Jane R Schwebke

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Antimicrobial resistance and natural alternatives:Frontiers in veterinary science · 2025
    Article
  3. Article
  4. Identification ofPathogens (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Secnidazole: a treatment for trichomoniasis in adolescents and adults.Expert review of anti-infective therapy · 2022
    Article
  7. Review
  8. A review onSouthern African journal of infectious diseases · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Management of Resistant Trichomoniasis.Current infectious disease reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Arindam P GhoshDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Cheri AycockDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jane R SchwebkeDivision of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA jschwebk@uabmc.edu.
University of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitroimidazoles (metronidazole [MTZ] and tinidazole [TNZ]) are the only drugs recommended for treatment of

Indexed as

Antiprotozoal AgentsMetronidazoleNitroimidazolesTrichomonas vaginalisAntiprotozoal AgentsMetronidazoleNitroimidazolessecnidazolemetronidazolenitroimidazolessecnidazoleTrichomonas vaginalis

Identifiers

PMID29439963
PMCPMC5913958
OpenAlexW2792916938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.